gastrointestinal cancer

Novartis, BeiGene lay out frontline PhIII data for PD-1 drug as second-line PDUFA date looms
Endpoints
Thu, 06/30/22 - 12:11 pm
Novartis
BeiGene
FDA
tislelizumab
gastrointestinal cancer
Blueprint posts 'impressive' data for lead candidate, but investor response tepid
Biopharma Dive
Fri, 11/16/18 - 08:06 pm
Blueprint Medicines
clinical trials
avapritinib
gastrointestinal cancer
Novartis cancer drug wins expanded indication in Europe
BioPharma Dive
Sat, 06/4/16 - 06:26 pm
Novartis
Europe
Afinitor
gastrointestinal cancer
Facing rival drugs, Novartis gets win with Afinitor in Europe
Yahoo/Reuters
Thu, 06/2/16 - 10:00 am
Novartis
Europe
Afinitor
cancer
gastrointestinal cancer
[video] Onyx Pharma CEO on New Cancer Drug
CNBC
Mon, 06/4/12 - 05:57 pm
ONYX Pharmaceuticals
Anthony Coles
Bayer
regorafenib
gastrointestinal cancer
Bayer Says Drug Held Off Gastrointestinal Tumors in Study
Bloomberg
Tue, 04/3/12 - 08:57 am
gastrointestinal cancer
Bayer
regorafenib
AB Soars 46% as Cancer Drug Beats Pfizer’s Sutent: Paris Mover
Bloomberg
Thu, 02/2/12 - 09:15 am
Pfizer
Sutent
AB Science
masitinib
gastrointestinal cancer
FDA grants faster review to Bayer's regorafenib
Yahoo/AP
Tue, 05/10/11 - 05:44 pm
Bayer
FDA
regorafenib
gastrointestinal cancer